A second dihydroorotate dehydrogenase (type A) of the human pathogen Enterococcus faecalis:: Expression, purification, and steady-state kinetic mechanism

被引:30
作者
Marcinkeviciene, J
Jiang, WJ
Locke, G
Kopcho, LM
Rogers, MJ
Copeland, RA
机构
[1] Dupont Merck Pharmaceut Co, Dept Chem Enzymol, Wilmington, DE 19880 USA
[2] Dupont Merck Pharmaceut Co, Antimicrobial Grp, Wilmington, DE 19880 USA
关键词
DHODase A; steady-state kinetic mechanism; quinone reduction; Enterococcus faecalis;
D O I
10.1006/abbi.2000.1769
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the identification, expression, and characterization of a second Dihydroorotate dehydrogenase (DHODase A) from the human pathogen Enterococcus faecalis. The enzyme consists of a polypeptide chain of 322 amino acids that shares 68% identity with the cognate type A enzyme from the bacterium Lactococcus lactis. E. faecalis DHODase A catalyzed the oxidation of L-dihydroorotate while reducing a number of substrates, including fumarate, coenzyme Q(0), and menadione. The steady-state kinetic mechanism has been determined with menadione as an oxidizing substrate at pH 7.5. Initial velocity and product inhibition data suggest that the enzyme follows a two-site nonclassical ping-pong kinetic mechanism. The absorbance of the active site FMN cofactor is quenched in a concentration-dependent manner by titration with orotate and barbituric acid, two competitive inhibitors with respect to dihydroorotate. In contrast, titration of the enzyme with menadione had no effect on FMN absorbance, consistent with nonoverlapping binding sites for dihyroorotate and menadione, as suggested from the kinetic mechanism. The reductive half-reaction has been shown to be only partially rate limiting, and an attempt to evaluate the slow step in the overall reaction has been made by simulating orotate production under steady-state conditions. Our data indicate that the oxidative half-reaction is a rate-limiting segment, while orotate, most likely, retains significant affinity for the reduced enzyme, as suggested by the product inhibition pattern. (C) 2000 Academic Press.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 32 条
[1]   2 DIFFERENT DIHYDROOROTATE DEHYDROGENASES IN LACTOCOCCUS-LACTIS [J].
ANDERSEN, PS ;
JANSEN, PJG ;
HAMMER, K .
JOURNAL OF BACTERIOLOGY, 1994, 176 (13) :3975-3982
[2]  
ANDREWS S, 1977, BIOCHIM BIOPHYS ACTA, V396, P229
[3]   The activity of Escherichia coli dihydroorotate dehydrogenase is dependent on a conserved loop identified by sequence homology, mutagenesis, and limited proteolysis [J].
Björnberg, O ;
Grüner, AC ;
Roepstorff, P ;
Jensen, KF .
BIOCHEMISTRY, 1999, 38 (10) :2899-2908
[4]   Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis [J].
Björnberg, O ;
Rowland, P ;
Larsen, S ;
Jensen, KF .
BIOCHEMISTRY, 1997, 36 (51) :16197-16205
[5]   Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide [J].
Bruneau, JM ;
Yea, CM ;
Spinella-Jaegle, S ;
Fudali, C ;
Woodward, K ;
Robson, PA ;
Sautès, C ;
Westwood, R ;
Kuo, EA ;
Williamson, RA ;
Ruuth, E .
BIOCHEMICAL JOURNAL, 1998, 336 :299-303
[6]   MECHANISM OF REDUCTION OF QUINONES BY TRYPANOSOMA-CONGOLENSE TRYPANOTHIONE REDUCTASE [J].
CENAS, NK ;
ARSCOTT, D ;
WILLIAMS, CH ;
BLANCHARD, JS .
BIOCHEMISTRY, 1994, 33 (09) :2509-2515
[7]  
CHEN SF, 1992, CANCER RES, V52, P3521
[8]  
Cleland W W, 1979, Methods Enzymol, V63, P103
[9]   The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase [J].
Davis, JP ;
Cain, GA ;
Pitts, WJ ;
Magolda, RL ;
Copeland, RA .
BIOCHEMISTRY, 1996, 35 (04) :1270-1273
[10]  
GIBSON QH, 1964, J BIOL CHEM, V239, P3927